Status:
UNKNOWN
Sofosbuvir in Treatment of COVID 19
Lead Sponsor:
Tanta University
Conditions:
COVID
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients
Detailed Description
Sofosbuvir containing treatment of COVID 19 Egyptian patients: a randomized-controlled trial
Eligibility Criteria
Inclusion
- Covid positive patients.
Exclusion
- Contraindication to sofosbuvir or ribavirin.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04460443
Start Date
August 1 2020
End Date
August 31 2021
Last Update
December 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sherief Abd-Elsalam
Tanta, Egypt